273 related articles for article (PubMed ID: 27401816)
1. A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.
Bisht S; Schlesinger M; Rupp A; Schubert R; Nolting J; Wenzel J; Holdenrieder S; Brossart P; Bendas G; Feldmann G
J Nanobiotechnology; 2016 Jul; 14(1):57. PubMed ID: 27401816
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.
Olivera A; Moore TW; Hu F; Brown AP; Sun A; Liotta DC; Snyder JP; Yoon Y; Shim H; Marcus AI; Miller AH; Pace TW
Int Immunopharmacol; 2012 Feb; 12(2):368-77. PubMed ID: 22197802
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin.
Kasinski AL; Du Y; Thomas SL; Zhao J; Sun SY; Khuri FR; Wang CY; Shoji M; Sun A; Snyder JP; Liotta D; Fu H
Mol Pharmacol; 2008 Sep; 74(3):654-61. PubMed ID: 18577686
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of novel
Xie X; Tu J; You H; Hu B
Drug Des Devel Ther; 2017; 11():1439-1451. PubMed ID: 28553074
[TBL] [Abstract][Full Text] [Related]
5. The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo.
Yang CH; Yue J; Sims M; Pfeffer LM
PLoS One; 2013; 8(8):e71130. PubMed ID: 23940701
[TBL] [Abstract][Full Text] [Related]
6. Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch.
Chen L; Li Q; Zheng Z; Xie J; Lin X; Jiang C; Xu H; Wu X; Wu J; Zhang H
Chem Biol Drug Des; 2019 Jul; 94(1):1368-1377. PubMed ID: 30873716
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
8. Biological Effects of EF24, a Curcumin Derivative, Alone or Combined with Mitotane in Adrenocortical Tumor Cell Lines.
Bertazza L; Barollo S; Mari ME; Faccio I; Zorzan M; Redaelli M; Rubin B; Armanini D; Mian C; Pezzani R
Molecules; 2019 Jun; 24(12):. PubMed ID: 31212829
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors.
Jin R; Chen Q; Yao S; Bai E; Fu W; Wang L; Wang J; Du X; Wei T; Xu H; Jiang C; Qiu P; Wu J; Li W; Liang G
Eur J Med Chem; 2018 Jan; 144():218-228. PubMed ID: 29351887
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity of an imageable curcuminoid 1-[2-aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH).
Lagisetty P; Subramaniam D; Sahoo K; Anant S; Awasthi V
Chem Biol Drug Des; 2012 Feb; 79(2):194-201. PubMed ID: 22107757
[TBL] [Abstract][Full Text] [Related]
11. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma.
Yin DL; Liang YJ; Zheng TS; Song RP; Wang JB; Sun BS; Pan SH; Qu LD; Liu JR; Jiang HC; Liu LX
Sci Rep; 2016 Aug; 6():32167. PubMed ID: 27571770
[TBL] [Abstract][Full Text] [Related]
12. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
Kunnumakkara AB; Guha S; Krishnan S; Diagaradjane P; Gelovani J; Aggarwal BB
Cancer Res; 2007 Apr; 67(8):3853-61. PubMed ID: 17440100
[TBL] [Abstract][Full Text] [Related]
13. Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy.
Thomas SL; Zhao J; Li Z; Lou B; Du Y; Purcell J; Snyder JP; Khuri FR; Liotta D; Fu H
Biochem Pharmacol; 2010 Nov; 80(9):1309-16. PubMed ID: 20615389
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog.
Liu H; Liang Y; Wang L; Tian L; Song R; Han T; Pan S; Liu L
PLoS One; 2012; 7(10):e48075. PubMed ID: 23118928
[TBL] [Abstract][Full Text] [Related]
15. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression.
Selvendiran K; Tong L; Vishwanath S; Bratasz A; Trigg NJ; Kutala VK; Hideg K; Kuppusamy P
J Biol Chem; 2007 Sep; 282(39):28609-28618. PubMed ID: 17684018
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer.
Wu J; Wu S; Shi L; Zhang S; Ren J; Yao S; Yun D; Huang L; Wang J; Li W; Wu X; Qiu P; Liang G
Eur J Med Chem; 2017 Jan; 125():1321-1331. PubMed ID: 27886548
[TBL] [Abstract][Full Text] [Related]
17. Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity.
Subramaniam D; May R; Sureban SM; Lee KB; George R; Kuppusamy P; Ramanujam RP; Hideg K; Dieckgraefe BK; Houchen CW; Anant S
Cancer Res; 2008 Mar; 68(6):1962-9. PubMed ID: 18339878
[TBL] [Abstract][Full Text] [Related]
18. EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1.
Thomas SL; Zhong D; Zhou W; Malik S; Liotta D; Snyder JP; Hamel E; Giannakakou P
Cell Cycle; 2008 Aug; 7(15):2409-17. PubMed ID: 18682687
[TBL] [Abstract][Full Text] [Related]
19. The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis.
Duan Y; Chen HL; Ling M; Zhang S; Ma FX; Zhang HC; Lv XA
Mol Cell Biol; 2022 Jan; 42(1):e0016321. PubMed ID: 34780286
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis.
Ranjan AP; Mukerjee A; Helson L; Gupta R; Vishwanatha JK
Anticancer Res; 2013 Sep; 33(9):3603-9. PubMed ID: 24023285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
